ONMD icon

OneMedNet

1.40 USD
+0.35
33.33%
At close Dec 20, 4:00 PM EST
After hours
1.43
+0.03
2.14%
1 day
33.33%
5 days
49.13%
1 month
66.67%
3 months
118.48%
6 months
14.75%
Year to date
88.93%
1 year
75.00%
5 years
-73.53%
10 years
-73.53%
 

About: OneMedNet Corp is a healthcare software company with solutions focused on digital medical image management, exchange, and sharing. It is a global provider of clinical imaging innovation and curator of regulatory-grade Imaging Real-World Data or iRWDTM. OneMedNet's innovative solutions connect healthcare providers and patients satisfying a crucial need within the Life Sciences field offering direct access to clinical images and the associated contextual patient record.

Employees: 20

0
Funds holding %
of 6,809 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

200% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 3

43% more funds holding

Funds holding: 14 [Q2] → 20 (+6) [Q3]

7.45% more ownership

Funds ownership: 17.82% [Q2] → 25.27% (+7.45%) [Q3]

11% less capital invested

Capital invested by funds: $4.15M [Q2] → $3.67M (-$473K) [Q3]

67% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 6

Research analyst outlook

We haven’t received any recent analyst ratings for ONMD.

Financial journalist opinion

Neutral
GlobeNewsWire
2 weeks ago
OneMedNet Announces Exciting New Collaboration with Bayer's AI Innovation Platform to Help Accelerate Healthcare AI Development
MINNEAPOLIS, Dec. 02, 2024 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) ("OneMedNet" or the "Company"), a Real-World Data (RWD) platform — has announced its collaboration with Bayer's AI Innovation Platform (AIIP). By joining AIIP, the partnership aims to empower the developer teams of healthcare organizations and startups in building scalable and compliant AI-powered medical imaging software products.
OneMedNet Announces Exciting New Collaboration with Bayer's AI Innovation Platform to Help Accelerate Healthcare AI Development
Neutral
GlobeNewsWire
3 weeks ago
OneMedNet Announces Receipt of Nasdaq Notice Regarding Delayed Form 10-Q
MINNEAPOLIS, Nov. 27, 2024 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet” or the “Company”), a global provider of clinical imaging innovation and curator of regulatory-grade Imaging Real World Data (“iRWD™”), inclusive of electronic health records, laboratory results and, uniquely, medical imaging, today announced the Company received an expected notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, due to the Company's failure to timely file its Form 10-Q for the fiscal quarter ended September 30, 2024 (the “New Delinquent Filing”) with the Securities and Exchange Commission (the “SEC”), the Company is not in compliance with Nasdaq's continued listing requirements under Nasdaq Listing Rule 5250(c)(1) (the “Rule”), which requires the timely filing of all required periodic reports with the SEC. Previously, Nasdaq granted the Company an exception until December 11, 2024 to file its delinquent Quarterly Reports on Form 10-Q for the quarterly periods ended March 31, 2024 and June 30, 2024 (collectively with the New Delinquent Filing, the “Delinquent Filings”).
OneMedNet Announces Receipt of Nasdaq Notice Regarding Delayed Form 10-Q
Neutral
GlobeNewsWire
1 month ago
OneMedNet Announces Continued Investment into Bitcoin
MINNEAPOLIS, Nov. 12, 2024 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) ("OneMedNet" or the "Company"), a pioneer in curating regulatory-grade Real World Data (RWD) including electronic health records, laboratory results, and medical imaging, has announced an additional strategic investment in Bitcoin. This investment is designed to enhance the company's financial resilience and support the expansion of its cutting-edge iRWD™ platform.
OneMedNet Announces Continued Investment into Bitcoin
Neutral
GlobeNewsWire
2 months ago
OneMedNet Announces Board Member Transition to Drive Growth Post-IPO
MINNEAPOLIS, Oct. 02, 2024 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet” or the “Company”), the leading curator of regulatory-grade Real World Data (RWD), is pleased to announce a strategic refresh of its Board of Directors following the successful transition to a publicly traded entity. This move reinforces our commitment to dynamic leadership and active engagement as we accelerate growth in this new phase.
OneMedNet Announces Board Member Transition to Drive Growth Post-IPO
Neutral
GlobeNewsWire
2 months ago
OneMedNet Announces Additional $1.7 Million Private Placement
MINNEAPOLIS, Sept. 26, 2024 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet” or the “Company”), the leading curator of regulatory-grade Real World Data ("RWD"), inclusive of electronic health records, laboratory results and, uniquely, medical imaging, today announced that it has entered into a securities purchase agreement with an affiliate of Off the Chain Capital (collectively, “Off the Chain”) in a follow-on private placement that resulted in gross proceeds of approximately $1.7 million, before deducting fees and expenses payable by the Company.
OneMedNet Announces Additional $1.7 Million Private Placement
Neutral
GlobeNewsWire
3 months ago
OneMedNet Announces Receipt of Nasdaq Notices Regarding Delayed Forms 10-Q
MINNEAPOLIS, Sept. 12, 2024 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet” or the “Company”), the leading curator of regulatory-grade Real World Data ("RWD"), inclusive of electronic health records, laboratory results and, uniquely, medical imaging, today announced the Company received an expected notice (the “First Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, due to the Company's failure to timely file its Form 10-Q for the fiscal quarter ended June 30, 2024 (the “Form 10-Q”) with the Securities and Exchange Commission (the “SEC”), the Company is not in compliance with Nasdaq's continued listing requirements under Nasdaq Listing Rule 5250(c)(1) (the “Rule”), which requires the timely filing of all required periodic reports with the SEC.
OneMedNet Announces Receipt of Nasdaq Notices Regarding Delayed Forms 10-Q
Neutral
GlobeNewsWire
3 months ago
OneMedNet appoints new CFO
MINNEAPOLIS, Sept. 10, 2024 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet” or the “Company”), the leading curator of regulatory-grade Real World Data (RWD), has announced that Bob Golden has joined the OneMedNet Executive Team as Chief Financial Officer spearheading all aspects of the company's financial and accounting operations while continuing to serve as a member of the Board of Directors.
OneMedNet appoints new CFO
Neutral
GlobeNewsWire
4 months ago
OneMedNet Revolutionizes Data Curation with AI, Boosting Efficiency up to 5X
MINNEAPOLIS, Aug. 09, 2024 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet” or the “Company”), the leading curator of regulatory-grade Real World Data (RWD), has successfully integrated its proprietary AI technology into its data curation process, ensuring rapid and precise de-identification of patient data. This innovation, coupled with other changes undertaken by the Company, has significantly reduced OneMedNet's operational costs, enabling the company to process vast amounts of clinical data in minutes rather than hours. Additionally, OneMedNet can now deliver longitudinal clinical data and images to Life Science organizations up to five times faster than before, as measured from the end-to-end data curation process, significantly expediting delivery.
OneMedNet Revolutionizes Data Curation with AI, Boosting Efficiency up to 5X
Neutral
GlobeNewsWire
4 months ago
OneMedNet Announces $4.6 Million Private Placement
Institutional investors include affiliates of Off the Chain Capital and Discovery Capital Management Institutional investors include affiliates of Off the Chain Capital and Discovery Capital Management
OneMedNet Announces $4.6 Million Private Placement
Neutral
GlobeNewsWire
5 months ago
Cytel Unveiled as OneMedNet's Newest Alliance Partner
Cytel's software products and services are utilized by hundreds of life science organizations, including the top 30 biopharmaceutical companies Cytel's software products and services are utilized by hundreds of life science organizations, including the top 30 biopharmaceutical companies
Cytel Unveiled as OneMedNet's Newest Alliance Partner
Charts implemented using Lightweight Charts™